CSTL

CASTLE BIOSCIENCES INC

CUSIP: 14843C105

Market Cap
-
Sector
Healthcare
Institutional Owners
0
Institutional Value
-

About

Castle Biosciences Inc. operates as a dermatology company specializing in the development and commercialization of prognostic tests for skin cancers and other dermatologic conditions. By utilizing proprietary gene expression profiling, the company provides clinicians with actionable genomic information to support personalized treatment decisions. Through these diagnostic tools, Castle Biosciences aims to improve patient outcomes by predicting disease recurrence and risk of metastasis.

Institutional Holders

Loading...